Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 9
Submit an article Journal homepage
355
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD

Keith Saylor NeuroScience, Inc., Herndon, VA, USACorrespondence[email protected]
,
David W. Williams Lilly USA, LLC, Indianapolis, IN, USA
,
Kory J. Schuh Lilly USA, LLC, Indianapolis, IN, USA
,
Linda Wietecha Lilly USA, LLC, Indianapolis, IN, USA
&
Michael Greenbaum Capstone Clinical Research, Libertyville, IL, USA
Pages 2087-2095 | Accepted 13 May 2010, Published online: 20 Jul 2010

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Timothy E. Wilens, Lenard A. Adler, Yoko Tanaka, Feng Xiao, Deborah N. D’Souza, Stephen W. Gutkin & Himanshu P. Upadhyaya. (2011) Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Current Medical Research and Opinion 27:12, pages 2309-2320.
Read now

Articles from other publishers (5)

Nicola C. Savill, Jan K. Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer, Himanshu P. Upadhyaya & David Coghill. (2015) The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research. CNS Drugs 29:2, pages 131-151.
Crossref
Nicola Savill & Chris J Bushe. (2012) A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?. Child and Adolescent Psychiatry and Mental Health 6:1.
Crossref
Michael R. KohnTracey W. TsangSimon D. Clarke. (2012) Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder. Clinical Medicine Insights: Pediatrics 6, pages CMPed.S7868.
Crossref
HaoSheng Sun, Paul J. Cocker, Fiona D. Zeeb & Catharine A. Winstanley. (2011) Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex. Psychopharmacology 219:2, pages 285-301.
Crossref
. (2011) Current World Literature. Current Opinion in Pediatrics 23:6, pages 700-707.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.